A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight
18h agoen
From the article
Conditions : Healthy; Obesity Interventions : Drug: BI 3034701; Drug: Placebo Sponsors : Boehringer Ingelheim Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Un estudio siguió a personas con prediabetes durante 21 años y encontró algo mejor que una pastilla
afsdp.org.pe·23h ago
How many Canadian employers are offering GLP-1 coverage for weight loss?
Canadian HR Reporter·1h ago
Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption
This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica
bmj.com·20d agohttps://doi.org/10.1056/NEJMoa2517384
doi.org·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.